Latest Hypogonadism News
Findings from the largest study to date examining the effect of TRT in prostate cancer patients build on previous evidence showing that the treatment does not affect disease progression risk.
Researchers find a higher incidence of clinically diagnosed urinary stones among men receiving testosterone replacement therapy (TRT) vs matched controls not on TRT.
The new guidelines focus on accurate assessment and proper monitoring.
Teen high consumers of food outside the home had 55% higher androgen-disruptor levels.
Screening and treating all healthy men older than 65 years with testosterone is discouraged.
Low sperm counts linked to hypogonadism, higher BMI, hypertension, dyslipidemia, metabolic syndrome
A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea.
In a study of hypogonadal men, those who received testosterone therapy had a lower incidence of prostate cancer than those who did not.
Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.
The later a man's testosterone level dropped below 12.1 nmol/L, the lower his lifetime risk for prostate cancer.
Testosterone use was also more likely at sites located in the West vs the Northeast and for care received at a community-based outpatient clinic versus a medical center.
Hypogonadal testicular cancer survivors had 15 times higher odds of metabolic syndrome than their eugonadal counterparts.
In type 2 diabetic male patients, a low testosterone level was found to be associated with anemia. These findings are consistent with previous reports.
Study demonstrates decreased risk of end-stage renal disease and all-cause mortality.
A population-based study showed no association between total prostate cancer risk and testosterone replacement therapy (TRT).
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)